We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

46 hedge funds and large institutions have $142M invested in Fibrocell Science Inc. in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

64% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 11

37% more capital invested

Capital invested by funds: $103M → $142M (+$38.8M)

7% more funds holding

Funds holding: 4346 (+3)

Holders
46
Holders Change
+3
Holders Change %
+6.98%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
7
Increased
18
Reduced
11
Closed
4
Calls
$81K
Puts
Net Calls
+$81K
Net Calls Change
+$80K
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$126K
ProShare Advisors
27
ProShare Advisors
Maryland
$119K +$117K +1,513 New
Janney Montgomery Scott
28
Janney Montgomery Scott
Pennsylvania
$110K -$8.84K -114 -8%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$88K -$3.02K -39 -3%
NFA
30
Nationwide Fund Advisors
Ohio
$87K
AIG
31
American International Group
New York
$79.7K +$1.86K +24 +2%
BA
32
BlackRock Advisors
Delaware
$66K +$9.54K +123 +17%
CS
33
Credit Suisse
Switzerland
$61K -$853 -11 -1%
GC
34
Guggenheim Capital
Illinois
$58K +$56.4K +728 New
Dimensional Fund Advisors
35
Dimensional Fund Advisors
Texas
$48K +$10.6K +137 +29%
Deutsche Bank
36
Deutsche Bank
Germany
$48K +$25.5K +329 +109%
Morgan Stanley
37
Morgan Stanley
New York
$35K +$30.1K +388 +616%
TRCT
38
Tower Research Capital (TRC)
New York
$23K +$14.1K +182 +169%
Barclays
39
Barclays
United Kingdom
$15K -$36.2K -467 -69%
Creative Planning
40
Creative Planning
Kansas
$11K
AllianceBernstein
41
AllianceBernstein
Tennessee
$7K +$4.65K +60 +176%
Bank of America
42
Bank of America
North Carolina
$1K -$46.5K -600 -99%
U
43
UBS
Switzerland
$1K +$620 +8 New
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$64 +$62.9K +811 New
SM
45
Sabby Management
Florida
-$363K -5,967 Closed
Group One Trading
46
Group One Trading
Illinois
-$7.05K -91 Closed
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
-$1.18K -19 Closed

FCSC Hedge Fund Activity: Q1 2014 in Review

46 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q1 2014, worth a combined $142M — up 37% from $103M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new FCSC positions and 4 closed out — a net gain of 3 holders — while 18 added to existing stakes and 11 trimmed.

The largest buyer was Third Security, adding an estimated $5.3M. The largest seller was Sabby Management, exiting entirely with an estimated $363K sold.

  • 46 institutional investors held Fibrocell Science Inc. (FCSC) as of Q1 2014, up from 43 in Q4 2013.
  • Funds reported $142M of Fibrocell Science Inc. stock for Q1 2014, up 37% quarter-over-quarter.
  • 7 funds opened new Fibrocell Science Inc. positions in Q1 2014 and 4 closed out, a net change of +3 holders.
  • The largest Fibrocell Science Inc. buyer in Q1 2014 was Third Security, an estimated $5.3M added.
  • The largest Fibrocell Science Inc. seller in Q1 2014 was Sabby Management, an estimated $363K sold.

Based on aggregated 13F filings for Q1 2014.